GLP-1 diabetes drugs linked to up to 68% higher hair loss risk

The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, a study published by The BMJ finds. Although the absolute risk is low, awareness of this potential effect may help inform shared treatment decisions, the researchers say.

Raccontata damedpagetoday.comindependent.co.ukmedicalxpress.comsciencealert.comhindustantimes.comirishtimes.comeuronews.comit.euronews.comgizmodo.comtheguardian.com